The choice depends on the goal (sleep quality, recovery, body composition, general growth hormone support), the patients response, tolerance for dosing frequency, and side effect considerations
The on-label and off-label use of GLP1RAs has gained popularity, driven by robust clinical research, documented benefits, and widely circulated claims on social media [1]
Results Twenty-seven participants were randomised to liraglutide ( n = 13) or placebo ( n = 14)
I tried it
In a separate meta-analysis, 21.7% of overweight/obese children were diagnosed with depression and 39.8% with anxiety, but only 18.0% of non-overweight/non-obese children had depression and 14.0% had anxiety, further stressing the importance of prioritizing effective treatment strategies4
Emerging evidence highlights how GLP-1 not only influences appetite and insulin secretion but also reshapes the gut microbiome (Singh et al, 2024)